Fluorescent Leishmania species: Development of stable GFP expression and its application for in vitro and in vivo studies

Experimental Parasitology

Volumn 127, Issue 3, 2011, Pages 637-645

  Bolhassani, Azam ^a   Taheri, Tahereh ^a   Taslimi, Yasaman ^a   Zamanilui, Soheila ^a,b   Zahedifard, Farnaz ^a   Seyed, Negar ^a   Torkashvand, Fatemeh ^a   Vaziri, Behrouz ^a   Rafati, Sima ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b SHAHED UNIVERSITY   (Iran)

Author keywords

Eukaryotic expression vector; Green fluorescent protein; Homologous recombination; Leishmania expression system; Leishmania species

Indexed keywords

GREEN FLUORESCENT PROTEIN;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE LOCUS; HOMOLOGOUS RECOMBINATION; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA TARENTOLAE; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; STRAIN DIFFERENCE; TRANSGENE; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL SEPARATION; CELLS, CULTURED; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENES, PROTOZOAN; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEISHMANIA; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGES; MICE; MICE, INBRED BALB C; ORGANISMS, GENETICALLY MODIFIED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSGENES;

ANIMALIA; EUKARYOTA; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA TARENTOLAE;

EID: 79951722752     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.12.006     Document Type: Article

References (29)

1. Basak A., Shervani N.J., Mbikay M., Kolajova M. Recombinant proprotein convertase 4 (PC4) from Leishmania tarentolae expression system: purification, biochemical study and inhibitor design. Protein Expression and Purification 2008, 60:117-126.
2. Basile G., Peticca M. Recombinant protein expression in Leishmania tarentolae. Molecular Biotechnology 2009, 43:273-278.
3. Boucher N., McNicoll F., Dumas C., Papadopoulou B. RNA polymerase I-mediated transcription of a reporter gene integrated into different loci of Leishmania. Molecular & Biochemical Parasitology 2002, 119:153-158.
4. Breitling R., Klingner S., Callewaert N., Pietrucha R., Geyer A., Ehrlich G., Hartung R., Muller A., Contreras R., Beverley S.M., Alexandrov K. Non-pathogenic trypanosomatid protozoa as a platform for protein research and production. Protein Expression and Purification 2002, 25:209-218.
5. Breton M., Zhao C., Ouellette M., Tremblay M.J., Papadopoulou B. A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection. Journal of General Virology 2007, 88:217-225.
6. Chan M.M.Y., Bulinski J.C., Chang K.P., Fong D. A microplate assay for Leishmania amazonensis promastigotes expressing multimeric green fluorescent protein. Parasitology Research 2003, 89(4):266-271.
7. Croan D.G., Morrison D.A., Ellis J.T. Evolution of the genus Leishmania revealed by comparison of DNA and RNA polymerase gene sequences. Molecular & Biochemical Parasitology 1997, 89:149-159.
8. D'Aiuto L., Robison C.S., Gigante M., Nwanegbo E., Shaffer B., Sukhwani M., Castro C.A., Chaillet J.R. Human IL-12p40 as a reporter gene for high throughput screening of engineered mouse embryonic stem cells. BMC Biotechnology 2008, 80:52-66.
9. Daneshvar H., Coombs G.H., Hagan P., Phillips S. Leishmania mexicana and Leishmania major: attenuation of wild-type parasites and vaccination with the attenuated lines. The Journal of Infectious Diseases 2003, 187:1662-1668.
10. Dube A., Gupta R., Singh N. Reporter genes facilitating discovery of drugs targeting protozoan parasites. Trends in Parasitology 2009, 25(9):432-439.
11. Dujardin J.C. Structure, dynamics and function of Leishmania genome: resolving the puzzle of infection, genetics and evolution?. Infection, Genetics and evolution 2009, 9:290-297.
12. Field K.G., Landfear S.M., Giovannoni S.J. 18S rRNA sequences of Leishmania enriettii promastigote and amastigote. International Journal for Parasitology 1991, 21(4):483-485.
13. Fritsche C., Sitz M., Weiland N., Breitling R., Pohl H.D. Characterization of the growth behavior of Leishmania tarentolae - a new expression system for recombinant proteins. Journal of Basic Microbiology 2007, 47:384-393.
14. Garg R., Dube A. Animal models for vaccine studies for visceral leishmaniasis. Indian Journal of Medical Research 2006, 123:439-454.
15. Kamau S.W., Grimm F., Hehl A.B. Expression of green fluorescent protein as a marker for effects of anti-leishmanial compounds in vitro. Antimicrobial Agents and Chemotherapy 2001, 45(12):3654-3656.
16. Kram D., Thale C., Kolodziej H., Kiderlen A.F. Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation. Journal of Immunological Methods 2008, 333:79-88.
17. Lang T., Goyard S., Lebastard M., Milon G. Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice. Cellular Microbiology 2005, 7(3):383-392.
18. Lang T., Lecoeur H., Prina E. Imaging Leishmania development in their host cells. Trends in Parasitology 2009, 25(10):464-473.
19. Mehta S.R., Huang R., Yang M., Zhang X.Q., Kolli B., Chang K.P., Hoffman R.M., Goto Y., Badaro R., Schooley R.T. Real-time in vivo green fluorescent protein imaging of a murine leishmaniasis model as a new tool for Leishmania vaccine and drug discovery. Clinical and Vaccine Immunology 2008, 15(12):1764-1770.
20. Miblitz A., Mottram J.C., Overath P., Aebischer T. Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes. Molecular & Biochemical Parasitology 2000, 107:251-261.
21. Mizbani A., Taheri T., Zahedifard F., Taslimi Y., Azizi H., Azadmanesh K., Papadopoulou B., Rafati S. Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis. Vaccine 2009, 28(1):53-62.
22. Monte-Alegre A., Quaissi A., Sereno D. Leishmania amastigotes as targets for drug screening. Kinetoplastid Biology and Disease 2006, 1:3.
23. Mureev S., Kushnir S., Kolesnikov A.A., Breitling R., Alexandrov K. Construction and analysis of Leishmania tarentolae transgenic strains free of selection markers. Molecular & Biochemical Parasitology 2007, 155:71-83.
24. Papadopoulou B., Dumas C. Parameters controlling the rate of gene targeting frequency in the protozoan parasite Leishmania. Nucleic Acids Research 1997, 25(21):4278-4286.
25. Papadopoulou B., Huang X.F., Boucher N., McNicoll F. Stage-specific regulation of gene expression in Leishmania. ASM News 2003, 69(6):282-288.
26. Peters N.C., Egen J.G., Secundino N., Debrabant A., Kimblin N., Kamhawi S., Lawyer P., Fay M.P., Germain R.N., Sacks D. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 2008, 321(5891):970-974.
27. Roy G., Dumas C., Sereno D., Wu Y., Singh A.K., Tremblay M.J., Ouellette M., Olivier M., Papadopoulou B. Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. Infections in macrophages and in animal models. Molecular and Biochemical Parasitology 2000, 110:195-206.
28. Singh N., Dube A. Fluorescent Leishmania: application to anti-leishmanial drug testing. The American journal of tropical medicine and hygiene 2004, 71(4):400-402.
29. Singh N., Gupta R., Jaiswal A.K., Sundar S., Dube A. Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening. Journal of Antimicrobial Chemotherapy 2009, 64:370-374.